Liraglutide (Saxenda) for Weight Loss

被引：1
|
作者：
Whitten, J. Suzin [1 ]
机构：
[1] Cambridge Hlth Alliance, Malden, MA 02148 USA
来源：
AMERICAN FAMILY PHYSICIAN | 2016年 / 94卷 / 02期
关键词：
TRIAL; TOLERABILITY;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：161 / 166
页数：6
相关论文
共 50 条
  • [1] Liraglutide (Saxenda) for Weight Loss
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1471): : 89 - 90
  • [2] Liraglutide (Saxenda) for Weight Loss
    Abramowicz, Mark
    Zuccotti, Gianna
    Pflomm, Jean-Marie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (11): : 1161 - 1162
  • [3] Clinical effectiveness of liraglutide on weight loss in South Koreans First real-world retrospective data on Saxenda in Asia
    Park, Joon Seok
    Kwon, Jieun
    Choi, Hyung Jin
    Lee, Changhyun
    MEDICINE, 2021, 100 (02) : E23780
  • [4] Falsified Ozempic (semaglutide) and Saxenda (liraglutide)
    Reactions Weekly, 2023, 1986 (1) : 2 - 2
  • [5] Liraglutide for weight loss
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (08): : 592 - 592
  • [6] Liraglutide induces weight loss
    Hutchinson E.
    Nature Reviews Gastroenterology & Hepatology, 2010, 7 (2) : 68 - 68
  • [7] Liraglutide for weight loss in obese people
    Hallberg, Par
    Schwan, Sofie
    Melhus, Hakan
    LANCET, 2010, 375 (9714): : 551 - 551
  • [8] Liraglutide (Saxenda®) for obesity in patients with pre-diabetes and cardiovascular risk in a tier three weight management setting
    Asir, R.
    Douek, I. F.
    King, R. J.
    Thomas, J. D.
    Lambert, A. P.
    Andrews, R. C.
    DIABETIC MEDICINE, 2022, 39
  • [9] BASELINE CHARACTERISTICS OF PATIENTS APPROVED FOR REIMBURSEMENT OF LIRAGLUTIDE (SAXENDA®) FOR WEIGHT MANAGEMENT UNDER A MANAGED ACCESS PROTOCOL IN IRELAND
    Barrett, R.
    Smith, A.
    Gorry, C.
    Doran, S.
    Barry, M.
    Mccullagh, L.
    VALUE IN HEALTH, 2024, 27 (12) : S321 - S321
  • [10] BASELINE CHARACTERISTICS OF PATIENTS APPLYING FOR REIMBURSMENT OF LIRAGLUTIDE (SAXENDA®) FOR WEIGHT MANAGEMENT UNDER A MANAGED ACCESS PROTOCOL IN IRELAND
    Gorry, C.
    Daly, M.
    Doran, S.
    Finnigan, K.
    Clarke, S.
    Barry, M.
    VALUE IN HEALTH, 2023, 26 (12) : S255 - S255
12345